Press Releases


April 27, 2026

QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone – Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths

QScreen AI Inc. has completed development of its patent-protected QAI physiological AI clinical platform, capable of identifying probable drug classes—including alcohol, opioids, benzodiazepines, stimulants, and cannabis—using only a standard laptop camera in real time. The…

Read full release →

February 27, 2026

QScreen arranges $500,000 private placement

Dr. Rahul Kushwah reports QSCREEN AI ANNOUNCES STRATEGIC FINANCING TO ADVANCE COMMERCIALIZATION INITIATIVES ACROSS NORTH AMERICA QScreen AI Inc. has arranged a non-brokered private placement. The company intends to issue up to 10 million units…

Read full release →

February 17, 2026

QScreen AI files patent application in U.S.

Dr. Rahul Kushwa reports QSCREEN AI ADVANCES QUANTUM-INSPIRED OPTIMIZATION WITH U.S. PATENT FILING; GAINS NATIONAL SPOTLIGHT ON CBC QScreen AI Inc. has filed a provisional patent application with the U.S. Patent and Trademark Office. Entitled…

Read full release →